Gavin P. Dunn, Ph.D. - Publications

Affiliations: 
2006 Washington University, Saint Louis, St. Louis, MO 
Area:
Immunology, Oncology

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Johanns TM, Miller CA, Liu CJ, Perrin RJ, Bender D, Kobayashi DK, Campian JL, Chicoine MR, Dacey RG, Huang J, Fritsch EF, Gillanders WE, Artyomov MN, Mardis ER, Schreiber RD, ... Dunn GP, et al. Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma. Oncoimmunology. 8: e1561106. PMID 30906654 DOI: 10.1080/2162402X.2018.1561106  0.96
2018 Zolkind P, Przybylski D, Marjanovic N, Nguyen L, Lin T, Johanns T, Alexandrov A, Zhou L, Allen CT, Miceli AP, Schreiber RD, Artyomov M, Dunn GP, Uppaluri R. Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma. Oncotarget. 9: 4109-4119. PMID 29423108 DOI: 10.18632/oncotarget.23751  0.96
2016 Johanns TM, Ward JP, Miller CA, Wilson C, Kobayashi DK, Bender D, Fu Y, Alexandrov A, Mardis ER, Artyomov MN, Schreiber RD, Dunn GP. Endogenous Neoantigen-specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach. Cancer Immunology Research. PMID 27799140 DOI: 10.1158/2326-6066.CIR-16-0156  0.96
2016 Law JM, Stark SC, Liu K, Liang NE, Hussain MM, Leiendecker M, Ito D, Verho O, Stern AM, Johnston SE, Zhang YL, Dunn GP, Shamji AF, Schreiber SL. Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1. Acs Medicinal Chemistry Letters. 7: 944-949. PMID 27774134 DOI: 10.1021/acsmedchemlett.6b00264  0.96
2016 Johanns TM, Fu Y, Kobayashi DK, Mei Y, Dunn IF, Mao DD, Kim AH, Dunn GP. High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathology. PMID 26960334 DOI: 10.1007/s10014-016-0257-5  0.96
2016 Bi WL, Abedalthagafi M, Horowitz P, Agarwalla PK, Mei Y, Aizer AA, Brewster R, Dunn GP, Al-Mefty O, Alexander BM, Santagata S, Beroukhim R, Dunn IF. Genomic landscape of intracranial meningiomas. Journal of Neurosurgery. 1-11. PMID 26771848 DOI: 10.3171/2015.6.JNS15591  0.96
2015 Luo LY, Kim E, Cheung HW, Weir BA, Dunn GP, Shen RR, Hahn WC. The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer. Molecular Cancer Research : McR. 13: 502-9. PMID 25368431 DOI: 10.1158/1541-7786.MCR-14-0407  0.96
2014 Aum DJ, Kim DH, Beaumont TL, Leuthardt EC, Dunn GP, Kim AH. Molecular and cellular heterogeneity: the hallmark of glioblastoma. Neurosurgical Focus. 37: E11. PMID 25434380 DOI: 10.3171/2014.9.FOCUS14521  0.96
2014 Hawasli AH, Kim AH, Dunn GP, Tran DD, Leuthardt EC. Stereotactic laser ablation of high-grade gliomas. Neurosurgical Focus. 37: E1. PMID 25434378 DOI: 10.3171/2014.9.FOCUS14471  0.96
2014 Woodworth GF, Dunn GP, Nance EA, Hanes J, Brem H. Emerging insights into barriers to effective brain tumor therapeutics. Frontiers in Oncology. 4: 126. PMID 25101239 DOI: 10.3389/fonc.2014.00126  0.96
2014 Onken MD, Winkler AE, Kanchi KL, Chalivendra V, Law JH, Rickert CG, Kallogjeri D, Judd NP, Dunn GP, Piccirillo JF, Lewis JS, Mardis ER, Uppaluri R. A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2873-84. PMID 24668645 DOI: 10.1158/1078-0432.CCR-14-0205  0.96
2014 Yang JC, Aronson JP, Dunn GP, Codd PJ, Buchbinder BR, Eskandar EN. Three-dimensional brain surface visualization for epilepsy surgery of focal cortical dysplasia. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 21: 1230-2. PMID 24485033 DOI: 10.1016/j.jocn.2013.12.004  0.96
2014 Dunn GP, Cheung HW, Agarwalla PK, Thomas S, Zektser Y, Karst AM, Boehm JS, Weir BA, Berlin AM, Zou L, Getz G, Liu JF, Hirsch M, Vazquez F, Root DE, et al. In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene. Proceedings of the National Academy of Sciences of the United States of America. 111: 1102-7. PMID 24385586 DOI: 10.1073/pnas.1311909111  0.96
2013 Tu D, Zhu Z, Zhou AY, Yun CH, Lee KE, Toms AV, Li Y, Dunn GP, Chan E, Thai T, Yang S, Ficarro SB, Marto JA, Jeon H, Hahn WC, et al. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Reports. 3: 747-58. PMID 23453972 DOI: 10.1016/j.celrep.2013.01.033  0.96
2013 Jones PS, Dunn GP, Barker FG, Curry WT, Hochberg FH, Cahill DP. Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium. Neurosurgical Focus. 34: E9. PMID 23373454 DOI: 10.3171/2012.12.FOCUS12349  0.96
2013 Dunn GP, Andronesi OC, Cahill DP. From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma. Neurosurgical Focus. 34: E2. PMID 23373447 DOI: 10.3171/2012.12.FOCUS12355  0.96
2013 Allen CT, Law JH, Dunn GP, Uppaluri R. Emerging insights into head and neck cancer metastasis. Head & Neck. 35: 1669-78. PMID 23280716 DOI: 10.1002/hed.23202  0.96
2013 Barbaro NM. Malignant nerve sheath tumors. Journal of Neurosurgery. 118: 140-1; discussion 14. PMID 23101449 DOI: 10.3171/2012.4.JNS11148  0.96
2013 Dunn GP, Spiliopoulos K, Plotkin SR, Hornicek FJ, Harmon DC, Delaney TF, Williams Z. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. Journal of Neurosurgery. 118: 142-8. PMID 23101443 DOI: 10.3171/2012.9.JNS101610  0.96
2012 Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF, Agarwalla PK, Chheda MG, Campos B, Wang A, Brennan C, Ligon KL, Furnari F, Cavenee WK, Depinho RA, et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes & Development. 26: 756-84. PMID 22508724 DOI: 10.1101/gad.187922.112  0.96
2012 Dunn GP, Fecci PE, Curry WT. Cancer immunoediting in malignant glioma. Neurosurgery. 71: 201-22; discussion 2. PMID 22353795 DOI: 10.1227/NEU.0b013e31824f840d  0.96
2012 Dunn GP, Nahed BV, Walcott BP, Jung H, Tierney TS, Ogilvy CS. Dual ipsilateral craniotomies through a single incision for the surgical management of multiple intracranial aneurysms. World Neurosurgery. 77: 502-6. PMID 22120339 DOI: 10.1016/j.wneu.2011.07.005  0.96
2012 Judd NP, Winkler AE, Murillo-Sauca O, Brotman JJ, Law JH, Lewis JS, Dunn GP, Bui JD, Sunwoo JB, Uppaluri R. ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Research. 72: 365-74. PMID 22086849 DOI: 10.1158/0008-5472.CAN-11-1831  0.96
2011 Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, Lee H, Arthur CD, White JM, Kalinke U, Murphy KM, Schreiber RD. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. The Journal of Experimental Medicine. 208: 1989-2003. PMID 21930769 DOI: 10.1084/jem.20101158  0.96
2011 O'Sullivan T, Dunn GP, Lacoursiere DY, Schreiber RD, Bui JD. Cancer immunoediting of the NK group 2D ligand H60a. Journal of Immunology (Baltimore, Md. : 1950). 187: 3538-45. PMID 21876033 DOI: 10.4049/jimmunol.1100413  0.96
2011 Cotter SE, Dunn GP, Collins KM, Sahni D, Zukotynski KA, Hansen JL, O'Farrell DA, Ng AK, Devlin PM, Wang LC. Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity. Archives of Dermatology. 147: 870-2. PMID 21768497 DOI: 10.1001/archdermatol.2011.176  0.96
2011 Dunn GP, Gerrard JL, Jho DH, Ogilvy CS. Surgical treatment of a large fusiform distal anterior cerebral artery aneurysm with In Situ end-to-side A3-A3 bypass graft and aneurysm trapping: case report and review of the literature. Neurosurgery. 68: E587-91; discussion . PMID 21135720 DOI: 10.1227/NEU.0b013e3182036012  0.96
2010 Agarwalla PK, Dunn GP, Laws ER. An historical context of modern principles in the management of intracranial injury from projectiles. Neurosurgical Focus. 28: E23. PMID 20568940 DOI: 10.3171/2010.2.FOCUS1038  0.96
2010 Wiedemeyer WR, Dunn IF, Quayle SN, Zhang J, Chheda MG, Dunn GP, Zhuang L, Rosenbluh J, Chen S, Xiao Y, Shapiro GI, Hahn WC, Chin L. Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proceedings of the National Academy of Sciences of the United States of America. 107: 11501-6. PMID 20534551 DOI: 10.1073/pnas.1001613107  0.96
2009 Refai D, Dunn GP, Santiago P. Giant cell tumor of the thoracic spine: case report and review of the literature. Surgical Neurology. 71: 228-33; discussion 2. PMID 18207522 DOI: 10.1016/j.surneu.2007.07.056  0.96
2008 Uppaluri R, Dunn GP, Lewis JS. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immunity. 8: 16. PMID 19053167  0.96
2008 Dunn GP, Lewis JS, Sunwoo JB, Uppaluri R. Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia. Head & Neck. 30: 267-72. PMID 17657794 DOI: 10.1002/hed.20701  0.96
2007 Dunn GP, Dunn IF, Curry WT. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immunity. 7: 12. PMID 17691714  0.96
2007 Dunn GP, Uppaluri R, Hessler JL, Layland MK, Derdeyn CP, Sunwoo JB. Mycotic pseudoaneurysm of the internal maxillary artery: case report and review of the literature. Archives of Otolaryngology--Head & Neck Surgery. 133: 402-6. PMID 17438257 DOI: 10.1001/archotol.133.4.402  0.96
2006 Sheehan KC, Lai KS, Dunn GP, Bruce AT, Diamond MS, Heutel JD, Dungo-Arthur C, Carrero JA, White JM, Hertzog PJ, Schreiber RD. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 26: 804-19. PMID 17115899 DOI: 10.1089/jir.2006.26.804  0.96
2006 Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nature Reviews. Immunology. 6: 836-48. PMID 17063185 DOI: 10.1038/nri1961  0.96
2006 Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Advances in Immunology. 90: 1-50. PMID 16730260 DOI: 10.1016/S0065-2776(06)90001-7  0.96
2005 Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD. Interferon-gamma and cancer immunoediting. Immunologic Research. 32: 231-45. PMID 16106075 DOI: 10.1385/IR:32:1-3:231  0.96
2005 Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. A critical function for type I interferons in cancer immunoediting. Nature Immunology. 6: 722-9. PMID 15951814 DOI: 10.1038/ni1213  0.96
2005 Dunn GP, Sheehan KC, Old LJ, Schreiber RD. IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression. Cancer Research. 65: 3447-53. PMID 15833880 DOI: 10.1158/0008-5472.CAN-04-4316  0.96
2004 Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 21: 137-48. PMID 15308095 DOI: 10.1016/j.immuni.2004.07.017  0.96
2004 Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annual Review of Immunology. 22: 329-60. PMID 15032581 DOI: 10.1146/annurev.immunol.22.012703.104803  0.96
2003 Popkin DL, Watson MA, Karaskov E, Dunn GP, Bremner R, Virgin HW. Murine cytomegalovirus paralyzes macrophages by blocking IFN gamma-induced promoter assembly. Proceedings of the National Academy of Sciences of the United States of America. 100: 14309-14. PMID 14614150 DOI: 10.1073/pnas.1835673100  0.96
2002 Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunology. 3: 991-8. PMID 12407406 DOI: 10.1038/ni1102-991  0.96
Show low-probability matches.